Health Condition 1: A415- Sepsis due to other Gram-negativeorganisms
Conditions
Interventions
Intervention1: Intravenous Mycobaterium (Mw) and Standard of care treatment: Inj. Sepsivac® 0.3 ml diluted in 10-100 ml NS to be given as slow IV infusion over at least 15 minutes, every day for 3 con
Sponsors
Medanta The Medicity
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients presumed to have gram-negative sepsis(Clinically Diagnosed) 2.Age between 18 to 65 years (both inclusive) 3.Agrees to Provide Consent
Exclusion criteria
Exclusion criteria: 1.History of allergic reactions attributed to Inj. Sepsivac® or any of its excipients 2. Pregnant and lactating women 3. Generalized septic skin conditions 4. Not willing to provide Consent 5. Patient not clinically diagnosed with Gram-ve sepsis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All Cause MortalityTimepoint: 28 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Days on ventilator and vasopressor, Intensive Care Unit length of stay, Change in SOFA score, To monitor adverse eventsTimepoint: 3, 7, 14, 28 days | — |
Countries
India
Contacts
Public ContactDr Yatin Mehta
Institute of Critical Care and Anesthesia
Outcome results
None listed